VAERS reports by lot

GSK DTaP/Tdap lot 7559R: VAERS reports

25 VAERS reports list lot 7559R as a GSK DTaP/Tdap vaccine, received between 2017-10-11 and 2019-05-16. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
25
Reports
8%
Marked serious
0
With a death outcome
12
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
Injection-site / Local reaction4662%
Cardiac / Cardiovascular811%
General / Systemic (non-local)79%
Allergic / Anaphylactic57%
Dermatological (non-injection-site)45%
Neurological23%
Gastrointestinal11%
Musculoskeletal11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California5
Michigan3
Kentucky2
Texas2
Missouri2
Idaho1
Utah1
South Carolina1
Pennsylvania1
Iowa1
Oklahoma1
Indiana1

Reports by month received

2017-103
2017-122
2018-012
2018-021
2018-044
2018-053
2018-064
2018-072
2018-081
2019-011
2019-041
2019-051

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.